Narcolepsy UK has agreed to assist in the completion of an international research project on the burden of narcolepsy and idiopathic hypersomnia sponsored by the pharmaceutical company Takeda (USA). The goal of this research is to better understand the impact of narcolepsy and idiopathic hypersomnia on quality of life, health care, and personal costs.
This study has now closed.
